Treatment

Displaying 11 - 20 of 323

Genome editing improves T-cells to attack cancer

Genome editing improves T-cells to attack cancer
Researchers at Cardiff University have found a way to boost the cancer-destroying ability of the immune system’s T-cells, offering new hope in the fight against a wide range of cancers. Using CRISPR genome editing, the team took the genetic engineering of killer T-cells one step further by removing their non-cancer specific receptors and replacing them with ones that would recognise specific cancer cells and destroy them.
21st November 2017

Hibernating squirrels inspire alternative stroke treatments

Hibernating squirrels inspire alternative stroke treatments
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels. While the animals' brains experience dramatically reduced blood flow during hibernation, just like human patients after a certain type of stroke, the squirrels emerge from their extended naps suffering no ill effects.
20th November 2017

LEDs light the way for optimised drug therapies

LEDs light the way for optimised drug therapies
Radioactivity may have a bad rap, but it plays a critical role in medical research. A revolutionary new technique to create radioactive molecules, pioneered in the lab of Princeton chemistry professor David MacMillan, has the potential to bring new medicines to patients much faster than before. “Your average drug takes 12 to 14 years to come to market,” said MacMillan, the James S. McDonnell Distinguished University Professor of Chemistry.
16th November 2017


Device for opioid withdrawal therapy approved by FDA

Device for opioid withdrawal therapy approved by FDA
The U.S. Food and Drug Administration granted a new indication to an electric stimulation device for use in helping to reduce the symptoms of opioid withdrawal. “Given the scope of the epidemic of opioid addiction, we need to find innovative new ways to help those currently addicted live lives of sobriety with the assistance of medically assisted treatment. There are three approved drugs for helping treat opioid addiction".
16th November 2017

Multi-Purpose inhaler produces different size medication droplets

Multi-Purpose inhaler produces different size medication droplets
Pneuma Respiratory has developed the first fully digital, soft mist inhaler. Early clinical studies have shown that the platform can effectively deliver a number of different types of medicines to the lungs. Pneuma's integrated device uses electronic breath actuation and a soft mist ejector. As a patient inhales, the ejector senses the breath and activates automatically. This allows the medication droplets to ride into the lungs on the patients' breath, without propellants.
14th November 2017

Care management platform enhances home healthcare

Care management platform enhances home healthcare
As our population is ageing there is a growing need for health checks and medicines management in a domestic setting. The PASSsystem from EveryLIFE Technologies is helping to increase the quality of that care and ensure service compliance.
13th November 2017

Neuroform Atlas stent system receives FDA HDE approval

Neuroform Atlas stent system receives FDA HDE approval
Stryker has announced that the U.S. Food and Drug Administration (FDA) has approved the Neuroform Atlas Stent System for marketing under a humanitarian device exemption (HDE). The device is to be utilised in conjunction with neurovascular embolic coils for the treatment of wide neck, intracranial, saccular aneurysms and allows the company to begin U.S. commercialisation efforts immediately.
13th November 2017

Nanoshells could deliver chemo with fewer side effects

Nanoshells could deliver chemo with fewer side effects
Researchers investigating ways to deliver high doses of cancer-killing drugs inside tumours have shown they can use a laser and light-activated gold nanoparticles to remotely trigger the release of approved cancer drugs inside cancer cells in laboratory cultures. The study by researchers at Rice University and Northwestern University Feinberg School of Medicine appears in the Proceedings of the National Academy of Sciences.
10th November 2017

Medication adherence solution aids chronically-ill patients

Medication adherence solution aids chronically-ill patients
  Vaica has announced the commercial availability of SimpleMed+, the latest addition to its medication adherence and telehealth management platform. SimpleMed+ is a medication dispenser for use by patients who take a number of oral medications per day.
10th November 2017

The latest treatment for childhood epilepsy

The latest treatment for childhood epilepsy
Epilepsy is a common chronic neurologic disorder that affects 1-3 % of the population. When it comes to childhood absence epilepsy (CAE), a paediatric formulation of an antiepileptic drug is long overdue. A significant proportion of epilepsy syndromes have their onset in childhood and adolescence, and there is a great heterogeneity with respect to syndrome type, causes and prognoses.
9th November 2017


Treatment documents


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

CES 2018
9th January 2018
United States of America Las Vegas, Nevada
Developing wearable products: technology and opportunities
17th January 2018
United Kingdom Cocoon Networks, London
Smart Mobility Executive Forum
12th February 2018
Germany Berlin
embedded world 2018
27th February 2018
Germany Nuremberg
Industry 4.0 Summit 2018
28th February 2018
United Kingdom Manchester